Report Code: A14035 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Lassa Virus Market
Request Now !Lassa virus, also known as the Lassa mammarenavirus (LASV), is the arenavirus known to cause Lassa hemorrhagic fever in humans and other primates. Lassa virus requires biosafety level-equivalent containments. It is an endemic in many West African countries such as the Republic of Guinea, Liberia, Nigeria, and Sierra Leona, where the annual number of Lassa viral fever cases is between 300,000 and 500,000, resulting in the annual death of 5,000 infected patients. The spread of the disease is linked to the village of Lassa in Nigeria where a missionary nurse first contracted it in 1969. In humans, the Lassa virus is spread through contact with infected Mastomyl natalensis, the multimammate rat.
COVID-19 Impact Analysis
Top Impacting Factors
Rising prevalence of Lassa fever in many developing economies and low-income countries is fuelling the growth of the Lassa virus market.Â
Growing population of Mastomys rats all over the world is another factor contributing to the growth of the Lassa virus market. Humans often become infected with the Lassa virus when they come in contact with the feces or urine of infected Mastomys rats.Â
Lassa virus is commonly widespread in some areas of Sierra Leone and Liberia; however, international travels from such regions to all corners of the world have increased the chances of the spreading of the virus. This factor is further contributing to the growth of the Lassa virus market.
However, the difficulty to diagnose the Lassa virus based on a patient's clinical presentation and the dearth of skilled healthcare professionals in low-income countries are some of the factors that are impeding the growth of the Lassa virus market.Â
Key Market Trends
Key Benefits of the Report
Lassa Virus Market Report Highlights
Aspects | Details |
---|---|
By Treatment |
|
By Diagnosis |
|
By End User |
|
By Region |
|
Key Market Players | Zydus Pharmaceuticals, F. Hoffmann La Roche AG, Sandoz Inc. (Novartis AG), Teva Pharmaceuticals, Valeant pharmaceuticals international, Three Rivers Pharmaceuticals LLC, Schering-Plough Research Institute |
Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers